This report highlights trends in Japan’s pharmaceutical market, notably how costly, long-listed products will be replaced due to generic and biosimilar industries continuing to grow in volume and market share. The report also discusses increased internationalisation of innovation, with a rise in acquisitions and partnerships with academia.

Report Download